Vascular patches are highly biocompatible, have little suture line bleeding due to their very elastic substance and excellent tissue assimilation, do not require impregnation or pre-clotting, and have good handling properties. Cardiovascular illnesses are the biggest cause of death, according to the World Health Organization (WHO), claiming nearly 17.9 million lives each year.
Frequently Asked Questions
The market is segmented based on Segmentation, By Material (Biologic, Synthetic), Application (Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysms, Vascular Bypass Surgery), End Users (Hospitals, Ambulatory Surgical Centers) - Industry Trends and Forecast to 2031
.
The Global Vascular Patches Market size was valued at USD 540.87 USD Million in 2023.
The Global Vascular Patches Market is projected to grow at a CAGR of 9% during the forecast period of 2024 to 2031.
The major players operating in the market include W. L. Gore & Associates, Anteris, Labcor Laboratórios, Johnson & Johnson Private Limited, Terumo Corporation, BD, B. Braun Melsungen AG, LeMaitre Vascular, Getinge AB, Baxter, Edwards Lifesciences Corporation, Neovasc , CryoLife, Medtronic, McKesson Medical Surgical , Agilent Technologies, Axogen Corporation, C. R. Bard .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
